C-reactive protein in anhedonia among patients with major depressive disorder and its relation to suicidal ideation
Article in Middle East Current Psychiatry (August 2024)
The most recent citing publications are shown below. View all 79 publications that cite this research output on Dimensions.
Minimal clinically important change in the MADRS anhedonia factor score: A pooled analysis of open-label studies with vortioxetine in patients with major depressive disorder
Article in Journal of Affective Disorders (July 2024)
Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study
Article in Neuropsychiatric Disease and Treatment (July 2024)